MedWatch

GN Hearing will prepare for continued logistical issues with million-dollar injection

In 2022, GN Hearing has put aside a total of DKK 150m (USD 23m) to secure a more robust supply chain. Most production is in China and Malaysia, which means the Danish hearing aid manufacturer is particularly exposed to global challenges. ”This is something that constantly – I’d actually say every day – has our full attention,” CEO Gitte Aabo says.

Gitte Aabo, CEO of GN Hearing | Photo: GN Hearing / PR

With a majority of production in facilities in China and Malaysia, hearing aid manufacturer GN Hearing is particularly exposed to fluctuations in the global supply chain. As the major logistical issues, left by the Covid-19 pandemic, look to continue for some time yet, the company has decided to take things into its own hands.

In 2022, GN Hearing is investing heavily into securing its own supply chain going forward.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs